Market Access: MedTech

Value-Based Access Programs

Communicating value to the market

Alira Health has the industry and market experience to communicate the value of your healthcare device or life science innovation. We specialize in helping early stage developers and late stage innovators communicate the hidden value of their products, increasing market access.

Solutions designed for commercial success

Our Center for Healthcare Economics and Outcomes Research (HEOR) team provides a range of solutions to communicate your value to the market and ensure commercial success. Our team works closely with clients to:
  • Identify key solutions that when implemented would satisfy a clear unmet need
  • Align internal messaging around the MAP™ diagnostic
  • Engage external stakeholders and develop a project charter
  • Identify local sites and clinical engagement
  • Monitor and track identified outcomes
  • Determine viability of program
  • Develop outcomes report
  • Scale up where possible

Why choose Alira Health?

Our fully integrated market access team understands the nuances of launching in today’s market. As your partner, we’ll provide:

  • Access to a diverse, integrated team with deep industry expertise
  • Close collaboration with our regulatory and clinical practices to support a holistic commercialization strategy
  • Specific, local insights as part of your larger, global strategy—a benefit of having market access teams in both the EU and U.S.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Richard Charter
Richard Charter
Vice President, Market Access, MedTech, Europe and Asia-Pacific
Our holistic, lifecycle approach to market access provides clients with maximum clinical and economic value for their technology while supporting patient-centered, value-based healthcare.

Related News

Market Access
Multimedia January 19, 2022
Alira Health’s Transformation Talks: Early Access Programs: Why and How?
Listen to this episode of "Transformation Talks" to discover the benefits and challenges of implementing EAPs from both the industry and payer perspectives and the main recommendations(...)
M&A MedTech Pharma
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
Market Access
Multimedia December 16, 2021
Alira Health’s Transformation Talks: Navigating the Vaccines’ Renaissance
Tune into this episode of "Transformation Talks" to learn more about the the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is coming up next. 
Market Access
Publications December 3, 2021
White Paper: Enhancing Patient Access with Early Access Programs
Pharmaceutical companies are facing an increasing demand from physicians for Early Access Programs (EAPs) and are willing to make their innovative medicines available to patients with(...)
Market Access
Events November 24, 2021
Event: ISPOR Europe 2021
Join Alira Health experts at virtual ISPOR.
Clinical Digital Health MedTech Pharma
News November 16, 2021
Alira Health Further Expands its Digital Healthcare Platform with the Acquisition of Patchai
We acquired Patchai, a digital health technology company headquartered in Italy. Patchai offers intelligent digital health solutions that engage and empower patients in clinical research(...)
Market Access
Events November 9, 2021
Event: National Forum for Innovation in Health Sciences 2021
Join the Alira Health team at National Forum for Innovation in Health Sciences 2021 on November 17.
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.